The MEVION S250 Proton Therapy System, which has not yet been cleared by the FDA for clinical use, will be housed in the Kling Center for Proton Therapy. The hospital plans to begin treating patients with the proton accelerator by the end of 2012 and expect to treat more than 200 patients a year.
Related Articles on Hospital Oncology and Proton Therapy:
Northwestern, Northern Illinois Partner With Treatment Center to Study Proton Beam Therapy
How Partnering with a Proton Center Can Boost a Hospital’s Oncology Program
Mayo Clinic Investing $370M on Experimental Cancer Treatment Centers
Register to Attend Webinar
Presenters:
Dawn Castro, Surgery Partners|Shannan Bolton, Stanford Health Care|Peter Thompson, UF Health|Michelle Castillon, Vee Healthtek
Next Up in Uncategorized
-
The FDA has approved Fayuvi (rebisufligene etisparvovec-hopf), the first treatment for pediatric patients with mucopolysaccharidosis type IIIA, also known as…
-
Healthcare leaders continue to grapple with an expanding list of threats to the industry’s stability, from workforce shortages and reimbursement…
-
Northwestern Medicine Bluhm Cardiovascular Institute has opened a new location in Tinley Park, Ill. The new clinic offers echocardiograms, supervised…
Join the 500,000+ healthcare executives who start their day with Becker's
Becker's Hospital Review Newsletter is sent Monday–Sunday.
